Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors.

Taylor EN, Mount DB, Forman JP, Curhan GC.

Am J Kidney Dis. 2006 May;47(5):780-9.

PMID:
16632016
2.

Pharmacotherapy of kidney stones.

Pak CY.

Expert Opin Pharmacother. 2008 Jun;9(9):1509-18. doi: 10.1517/14656566.9.9.1509 . Review.

PMID:
18518781
3.

Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism.

Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB.

J Nephrol. 2000 May-Jun;13(3):169-77. Review.

PMID:
10928292
4.

Hypertension, calcium metabolism, and nephrolithiasis.

Strazzullo P, Mancini M.

Am J Med Sci. 1994 Feb;307 Suppl 1:S102-6. Review.

PMID:
8141146
5.

Low urinary citrate: an overview.

Zacchia M, Preisig P.

J Nephrol. 2010 Nov-Dec;23 Suppl 16:S49-56. Review.

PMID:
21170889
6.

Dietary therapy for patients with hypocitraturic nephrolithiasis.

Kurtz MP, Eisner BH.

Nat Rev Urol. 2011 Mar;8(3):146-52. doi: 10.1038/nrurol.2011.9. Epub 2011 Feb 15. Review.

PMID:
21321574
7.

Is there a need for medical evaluation and treatment of nephrolithiasis in the "age of lithotripsy"?

Preminger GM.

Semin Urol. 1994 Feb;12(1):51-64. Review. No abstract available.

PMID:
8197337
8.

Citrate and mineral metabolism: kidney stones and bone disease.

Caudarella R, Vescini F, Buffa A, Stefoni S.

Front Biosci. 2003 Sep 1;8:s1084-106. Review.

PMID:
12957820

Supplemental Content

Support Center